Business Combinations - Schedule of Consideration (Details) - NDAG [Member] |
6 Months Ended |
|---|---|
|
Jun. 30, 2026
USD ($)
$ / shares
shares
| |
| Schedule of Consideration [Line Items] | |
| Fair Value | $ 1,515,556,855 |
| Class A Common Stock [Member] | |
| Schedule of Consideration [Line Items] | |
| Number of Instruments | shares | 59,346,944 |
| Fair Value Per Unit | $ / shares | $ 7.29 |
| Fair Value | $ 432,639,220 |
| Pre-funded warrants [Member] | |
| Schedule of Consideration [Line Items] | |
| Number of Instruments | shares | 98,264,309 |
| Fair Value Per Unit | $ / shares | $ 7.29 |
| Fair Value | $ 716,336,988 |
| Note payable [Member] | |
| Schedule of Consideration [Line Items] | |
| Fair Value | $ 366,580,647 |
| X | ||||||||||
- Definition Amount of fair value of per unit under business combination consideration transferred. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of shares of equity interest issued or issuable by acquirer as part of consideration transferred in business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|